Accounting policy
Non-controlling interests in subsidiaries are measured at the proportionate share of the subsidiaries’ identifiable net assets.
|
|
2024 |
|
2023 |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
DRT-Anthea Aroma |
|
Andre Pectin |
|
Yimante |
|
Other |
|
Total |
|
|
% of non-controlling interest |
|
50%/0% |
|
25% |
|
25% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at 1 January |
|
21 |
|
48 |
|
61 |
|
32 |
|
162 |
|
102 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes: |
|
|
|
|
|
|
|
|
|
|
|
|
- Share of profit/charged to income statement |
|
2 |
|
4 |
|
19 |
|
5 |
|
30 |
|
16 |
- Dividend paid |
|
(2) |
|
– |
|
– |
|
(5) |
|
(7) |
|
– |
- Acquisitions |
|
– |
|
– |
|
– |
|
– |
|
– |
|
48 |
- Divestments |
|
(21) |
|
– |
|
– |
|
4 |
|
(17) |
|
(4) |
- Other consolidation changes |
|
– |
|
– |
|
– |
|
(6) |
|
(6) |
|
– |
- Transfers |
|
– |
|
– |
|
19 |
|
– |
|
19 |
|
9 |
- Exchange differences |
|
– |
|
2 |
|
2 |
|
1 |
|
5 |
|
(9) |
Total changes |
|
(21) |
|
6 |
|
40 |
|
(1) |
|
24 |
|
60 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at 31 December |
|
– |
|
54 |
|
101 |
|
31 |
|
186 |
|
162 |
The shareholding owned by dsm-firmenich in Yimante Health Ingredients (Jingzhou) Company Ltd. is 75%. The profit will be distributed in a 50:50 proportion. The impact of this arrangement has led to a transfer of €19 million (2023: €9 million) within equity from shareholders’ equity to non-controlling interest.
In the reporting period, dsm-firmenich divested half of its 50% equity stake in DRT-Anthea and lost control. Therefore, this investment is deconsolidated.
For acquisitions, see Note 3 Change in the scope of consolidation.
|
|
2024 |
|
2023 |
||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
|
Andre Pectin |
|
Yimante |
|
Other |
|
Total |
|
|
Assets |
|
|
|
|
|
|
|
|
|
|
Goodwill and intangible assets |
|
37 |
|
19 |
|
1 |
|
57 |
|
122 |
Property, plant and equipment |
|
38 |
|
121 |
|
31 |
|
190 |
|
275 |
Other non-current assets |
|
2 |
|
40 |
|
25 |
|
67 |
|
95 |
Inventories |
|
51 |
|
10 |
|
64 |
|
125 |
|
143 |
Receivables |
|
31 |
|
111 |
|
73 |
|
215 |
|
186 |
Current investments |
|
7 |
|
– |
|
– |
|
7 |
|
51 |
Cash and cash equivalents |
|
73 |
|
9 |
|
63 |
|
145 |
|
103 |
Total assets |
|
239 |
|
310 |
|
257 |
|
806 |
|
975 |
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
Provisions (non-current) |
|
10 |
|
1 |
|
2 |
|
13 |
|
24 |
Borrowings (non-current) |
|
– |
|
13 |
|
16 |
|
29 |
|
95 |
Other non-current liabilities |
|
– |
|
1 |
|
6 |
|
7 |
|
9 |
Borrowings and derivatives (current) |
|
– |
|
13 |
|
6 |
|
19 |
|
74 |
Other current liabilities |
|
10 |
|
32 |
|
62 |
|
104 |
|
159 |
Total liabilities |
|
20 |
|
60 |
|
92 |
|
172 |
|
361 |
|
|
|
|
|
|
|
|
|
|
|
Net assets (100% basis) |
|
219 |
|
250 |
|
165 |
|
634 |
|
614 |
|
|
|
|
|
|
|
|
|
|
|
Net sales |
|
96 |
|
277 |
|
333 |
|
706 |
|
620 |
Net profit for the year |
|
19 |
|
74 |
|
30 |
|
123 |
|
70 |
Cash provided by/(used in) operating activities |
|
27 |
|
71 |
|
55 |
|
153 |
|
154 |